Lastly, within the context of C9ORF72-ALS-FTD, targeting RAB GTPases could serve as a potential therapeutic strategy, as RAB GTPases are extensively involved in the biogenesis and function of endosomal-lysosomal systems (Langemeyer et al., 2018). This evidence concerns the gene RAB6A and amyotrophic lateral sclerosis.